Cryoport, Inc. (CYRX) stock
CYRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 11/3021% above fair value
$19.74−0.06 (-0.30%)
Close on Nov 17, 2026Market cap $999.81MP/E –Yield –
Cryoport total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Cryoport's total debt was $985.00K at Jun 30, 2026. For fiscal 2025 it was $1.09M, down 2.4% from the year before. The highest annual figure on record is $4.91M in fiscal 2020.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.09M | -2.4% |
| FY2024 | Dec 31, 2024 | $1.11M | -16.6% |
| FY2023 | Dec 31, 2023 | $1.34M | +276.1% |
| FY2022 | Dec 31, 2022 | $355.00K | -67.3% |
| FY2021 | Dec 31, 2021 | $1.09M | -77.9% |
| FY2020 | Dec 31, 2020 | $4.91M | – |
| FY2019 | Dec 31, 2019 | $0 | – |
Quarterly total debt
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026CQ2 2026 | Jun 30, 2026 | $985.00K | -25.8% |
| Q1 FY2026CQ1 2026 | Mar 31, 2026 | $1.03M | -8.5% |
| Q4 FY2025CQ4 2025 | Dec 31, 2025 | $1.09M | -2.4% |
| Q3 FY2025CQ3 2025 | Sep 30, 2025 | $1.29M | +4.3% |
| Q2 FY2025CQ2 2025 | Jun 30, 2025 | $1.33M | +5.6% |
| Q1 FY2025CQ1 2025 | Mar 31, 2025 | $1.12M | -14.0% |
| Q4 FY2024CQ4 2024 | Dec 31, 2024 | $1.11M | -16.6% |
| Q3 FY2024CQ3 2024 | Sep 30, 2024 | $1.24M | +303.3% |
| Q2 FY2024CQ2 2024 | Jun 30, 2024 | $1.26M | +262.5% |
| Q1 FY2024CQ1 2024 | Mar 31, 2024 | $1.31M | +258.5% |
| Q4 FY2023CQ4 2023 | Dec 31, 2023 | $1.34M | +276.1% |
| Q3 FY2023CQ3 2023 | Sep 30, 2023 | $307.00K | -12.5% |
| Q2 FY2023CQ2 2023 | Jun 30, 2023 | $347.00K | -7.2% |
| Q1 FY2023CQ1 2023 | Mar 31, 2023 | $364.00K | -65.3% |
| Q4 FY2022CQ4 2022 | Dec 31, 2022 | $355.00K | -67.3% |
| Q3 FY2022CQ3 2022 | Sep 30, 2022 | $351.00K | -92.2% |
| Q2 FY2022CQ2 2022 | Jun 30, 2022 | $374.00K | -91.8% |
| Q1 FY2022CQ1 2022 | Mar 31, 2022 | $1.05M | -70.0% |
| Q4 FY2021CQ4 2021 | Dec 31, 2021 | $1.09M | -77.9% |
| Q3 FY2021CQ3 2021 | Sep 30, 2021 | $4.51M | – |
| Q2 FY2021CQ2 2021 | Jun 30, 2021 | $4.57M | – |
| Q1 FY2021CQ1 2021 | Mar 31, 2021 | $3.50M | – |
| Q4 FY2020CQ4 2020 | Dec 31, 2020 | $4.91M | – |
| Q4 FY2019CQ4 2019 | Dec 31, 2019 | $0 | – |
See a number that looks wrong?